Pfizer releases top-line results from PHN and pDPN trials of Lyrica
Pfizer has reported top-line results from two placebo-controlled trials carried out in China with Lyrica (pregabalin) in patients with postherpetic neuralgia (pain after shingles or PHN) and painful diabetic peripheral neuropathy (pDPN), respectively…
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Diabetes | Endocrinology | Lyrica | Neurology | Pain | Peripheral Neuropathy | Pfizer | Pharmaceuticals | Shingles